Huminn

About Huminn

Huminn is a pioneering company specializing in molecular diagnostics, prognostics, and therapeutic optimization. The company serves healthcare providers, research institutions, and biotech firms, operating primarily in the healthcare and biotechnology markets. Huminn's business model revolves around developing and commercializing advanced diagnostic tools and therapies that leverage molecular and liquid biopsy technologies. Revenue is generated through the sale of diagnostic tests, licensing of proprietary technologies, and partnerships with healthcare organizations. The company has a global presence with locations in the United States and Israel, focusing on solving health, wellness, and sustainable development challenges.